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Abstract
Introduction
Chronic health conditions are considered ambulatory care–
sensitive conditions (ACSC) when the illness is controllable 
with effective and timely outpatient care that can potentially 
prevent the need for hospitalizations. Hospitalization rates 
for ACSC serve as an indicator of the access to and quality 
of primary care for chronic conditions. Standard methods to 
calculate hospitalization rates incorporate the total popula-
tion in the denominator instead of the total population at 
risk for a hospitalization. By accounting for people with an 
ACSC, this study compares standard methods to a disease 
prevalence–adjusted method to highlight the importance of 
adjusting for ACSC prevalence when using ACSC hospital-
izations in assessing primary care outpatient services.
Methods
We combined California Health Interview Survey and hos-
pital discharge data to calculate standard (crude and age-
adjusted) and disease prevalence-adjusted hospitalization 
rates for hypertension and congestive heart failure. To 
compare rate calculations, we ranked California counties 
by their hospitalization rate.
Results
Counties had high prevalence and low numbers of hospital-
izations for hypertension; their rankings for hospitalization 
rates for hypertension did not vary, even after accounting 
for prevalence. In contrast, counties had low prevalence 
and high numbers of hospitalizations for congestive heart 
failure; their rankings varied substantially for congestive 
heart failure after accounting for prevalence.
Conclusion
Because the number of people diagnosed with an ACSC 
is rising and costs to treat these conditions are increas-
ing, our findings suggest that more accurate measures 
of ACSC hospitalization rates are needed. Incorporating 
disease prevalence will contribute to ACSC research by 
improving the validity of hospitalization rates as a mea-
sure for quality of primary care services.
Introduction
Chronic health conditions are the leading cause of death 
and disability in the United States and are the largest 
component of health care costs (1,2). Some chronic health 
conditions are deemed ambulatory care–sensitive condi-
tions (ACSC) because they are controllable with effective 
and timely outpatient care and disease management (3). 
Rates of ACSC hospitalizations are used by public health 
officials to measure accessibility and effectiveness of 
primary health care services (4-6) and to control health 
costs for ACSCs. The Agency for Healthcare Research and 
Quality (AHRQ) used hospital inpatient discharge data to 
develop a set of Prevention Quality Indicators (PQIs) to 
assess ACSC hospitalizations (7,8).
Common ways to report hospitalization rates include 
crude and age-adjusted rates (9,10). These rate calcula-
tions use the total number of people in a population. Crude 
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rates often serve as a summary measure that captures the 
overall burden of hospitalizations in the total population 
(11). ACSCs may be confounded by individual demograph-
ic characteristics, such as age, that have a heightened risk 
for being hospitalized. Adjusting by these factors is a com-
mon way to remove differences caused by demographics 
instead of health systems when comparing different popu-
lations. The process of adjusting provides a hypothetical 
rate that would be observed in a population if, for example, 
the age distribution of the group were the same as the age 
distribution of the standard population (9).
In traditional rate calculations, we assume that the events 
such as hospitalizations (numerator) occur among the 
population at risk (denominator). When calculating hos-
pitalization rates, the true at-risk population is limited to 
those who have an ACSC. By using the number of people 
who report being diagnosed with an ACSC in the denomi-
nator, we can calculate a disease prevalence–adjusted rate 
that should more accurately reflect potentially avoidable 
hospitalizations.
We assessed the value of incorporating disease prevalence 
into the denominator in hospitalization-rate calculations. 
Using California Health Interview Survey (CHIS) data 
and hospital discharge data, this study examines stan-
dard and disease prevalence-adjusted ACSC hospitaliza-
tion rates for hypertension and congestive heart failure 
(CHF) among California adults. By comparing a disease 
prevalence–adjusted rate with standard-rate calculations, 
we hypothesized that prevalence–adjusted hospitalization 
rates would highlight areas with higher ACSC burden.
Methods
We combined population-based data from CHIS and hos-
pitalization data from the California Office of Statewide 
Health Planning and Development’s (OSHPD’s) hospital 
patient discharge files. This study received institutional 
review board approvals from the University of California, 
Los Angeles (UCLA) Human Subjects Protection 
Committee, the California Health and Human Services 
Agency, and the California OSHPD.
Data sources
Conducted every other year since 2001, CHIS is a ran-
dom-digit–dialed telephone survey of California’s nonin-
stitutionalized population. On average, there are 45,000 
completed CHIS interviews with adults aged 18 years or 
older per data collection year. CHIS data from 2003, 2005, 
and 2007 were pooled and weighted to adjust for geo-
graphic oversampling and to reflect California population 
characteristics. ACSC prevalence, population size, and 
demographic characteristics were obtained at the county 
level from CHIS data.
The OSHPD hospital patient discharge dataset comprises 
a record for each inpatient discharged from a licensed 
acute care hospital in California. We used patient dis-
charge data from OSPHD of respondents aged 18 years or 
older from 2004 through 2006, which included more than 
11 million records. From the OSPHD dataset, we used 
principal diagnosis, source or type of admission, discharge 
date, and patient-level characteristics. Because of small 
population sizes, 19 counties were grouped into 4 county 
clusters. Both Los Angeles and San Diego counties were 
subdivided into smaller subcounty areas. Data were man-
aged and analyzed in Microsoft Excel 2007 and SAS ver-
sion 9.2 (SAS Institute, Inc, Cary, North Carolina).
Identifying ACSC conditions and hospitalizations
We chose 2 chronic conditions on the basis of AHRQ’s 
PQIs: hypertension (PQI no. 7) and CHF (PQI no. 8). For 
disease prevalence, we used CHIS data of adults reporting 
ever being diagnosed with hypertension or CHF by a doc-
tor. Estimates and variances of disease prevalence at the 
county level were pooled from CHIS 2003, 2005, and 2007. 
For areas with a small number of events, we imputed 
the disease prevalence estimate on the basis of similar 
county size characteristics (eg, population size, disease 
prevalence, hospitalizations). To identify ACSC hospital-
izations, we used principal diagnosis as defined by the 
International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) (Appendix A). The aver-
age annual number of hospitalizations between 2004 and 
2006 was used to obtain more stable hospitalization rates 
at the county level from OSHPD data.
Rate calculations
We calculated crude, disease prevalence–adjusted, age-
adjusted, and combined age-and prevalence-adjusted hos-
pitalization rates for hypertension and CHF. Crude rates 
were calculated with number of hospitalizations in county 
as the numerator and total population in county as the 
denominator (9). For disease prevalence–adjusted rates, 
the total number of people reporting the ACSC in the 
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county served as the denominator. We used the direct 
method to calculate the age-adjusted hospitalization rate. 
First, age-specific hospitalization rates were calculated for 
each age group using the total number of hospitalizations 
for a given age group as the numerator and  the total num-
ber of people in the population for a given age group as 
the denominator (9,11). Second, age-specific weights were 
calculated for each age group to capture the frequency of 
people in the total population for each age group. By sum-
ming the product of the age-specific hospitalization rate 
with the age-specific weights, we obtained the age-adjust-
ed hospitalization rate. To incorporate disease prevalence 
into this rate, the total number of people reporting the 
ACSC served as the denominator for the age-specific hos-
pitalization rates. The 95% confidence intervals for each 
hospitalization rate were also calculated to account for 
sampling variation (Appendix B).
All rates were aggregated at the California county level and 
subcounty level for Los Angeles and San Diego counties. 
Hospitalization rates were expressed per 100,000 people 
in the population (for the crude and age-adjusted rates) or 
per 100,000 people reporting the ACSC in the population 
(for the disease prevalence–adjusted and age- and disease 
prevalence–adjusted rates). To compare across counties, 
age-adjusted and age- and disease prevalence-adjusted 
rates were standardized (ie, process of comparing counties) 
by using 2000 US Census population data (12). To compare 
different rate calculations, we ranked counties from lowest 
(rank of 1) to highest (rank of 55) by their hospitalization 
rate. Counties were then grouped into quintiles with group 
1 representing areas with the lowest hospitalization rates 
(indicating better access to or quality of primary care) and 
group 5 representing areas with the highest rates (indicat-
ing the worst access to or quality of primary care).
Results
In this study, we compared hospitalization rates that do 
and do not incorporate disease prevalence. We first pres-
ent disease prevalence, average number of hospitaliza-
tions per year, and age-specific rates. Next, age-adjusted 
and combined age- and disease prevalence–adjusted hos-
pitalization rates are discussed. Results are presented 
separately for each ACSC.
Hypertension
The annual prevalence of hypertension was high (24.8%) 
(Table 1). Despite high prevalence, the average number of 
hospitalizations was low (6,355 total statewide per year). 
Older adults showed the highest age-specific hospitaliza-
tion rate for hypertension at 95 per 100,000 people aged 75 
years or older compared with people aged 65 to 74 years 
(58 per 100,000), 45 to 64 years (30 per 100,000), and 18 
to 44 years (7 per 100,000) (Figure 1). After accounting for 
disease prevalence, the population at risk for hospitaliza-
tions became smaller, and thus the age-specific rates per 
100,000 people were higher but followed the same age pat-
tern (Figure 1). In comparison with the age-specific rate, 
the age- and disease prevalence–specific rate among peo-
ple aged 75 years or older was about 50% higher (154 per 
100,000) among those who reported ever being diagnosed 
with hypertension compared with the total population.
Figure 1. Age-specific and age- and prevalence-specific hospitalization rates 
for hypertension among California adults. Source: California Health Interview 
Survey and OSHPD Hospital Patient Discharge Data. Abbreviation: Office of 
Statewide Health Planning and Development. 
There was a low hospitalization rate of hypertension at 
24 per 100,000 people (Table 1). After accounting for dis-
ease prevalence, the rate was 97 per 100,000 people who 
reported ever being diagnosed with hypertension. After 
adjusting for age, the rates were 25 for the age-adjusted 
rate and 82 for the age- and disease prevalence-adjusted 
rate. Comparing across county rankings, counties that 
ranked low for the age-adjusted rate also ranked low for 
the combined adjusted rate (Table 2). A similar pattern 
emerged for counties that had high age-adjusted rates and 
high age- and prevalence-adjusted rates. Only 14 counties 
differed in group ranking by 1 position.
Congestive heart failure 
The annual prevalence of CHF (1.6%) was much lower 
than the hypertension prevalence. In contrast, the average 
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number of hospitalizations was higher (65,389 per year) 
(Table 1). Across age groups, the highest age-specific hos-
pitalization rate appeared among adults aged 75 years or 
older (1,775 per 100,000) followed by adults aged 64 to 74 
years (673 per 100,000) and 18 to 64 years (82 per 100,000) 
(Figure 2). After adjusting for age and disease prevalence, 
the age-specific rates increased substantially because of the 
small prevalence of CHF in the total population. Both rates 
showed a similar pattern in age distribution (Figure 2).
 
Figure 2. Age-specific and age- and prevalence-specific hospitalization rates 
for CHF among California adults. Source: California Health Interview Survey 
and OSHPD Hospital Patient Discharge Data. Abbreviation: OSHPD, Office of 
Statewide Health Planning and Development. 
The overall CHF hospitalization rate was 249 per 100,000 
(Table 1). After accounting for disease prevalence, the 
overall rate jumped to 16,773 hospitalizations per 100,000 
people who reported ever being diagnosed with CHF. The 
CHF hospitalization rate increased slightly from the crude 
rate of 249 to the age-adjusted rate of 270. The combined 
age- and prevalence-adjusted hospitalization rate was 
10,633 per 100,000 people who reported ever being diag-
nosed with CHF. Accounting for age reduced the CHF 
hospitalization rate in the combined adjusted rate.
CHF rate comparisons show that the group rankings of 31 
counties changed, and among them, 15 counties changed 
by 2 or more quintiles  (Table 3). Of the 11 counties that 
ranked the best in the age-adjusted rates, 3 counties 
changed by at least 2 positions from age-adjusting to the 
combined age- and prevalence-adjusted rate. Los Angeles 
SPA 5 ranked in group 1, and Santa Barbara and Santa 
Clara only ranked in group 2 in the age-adjusted rates; 
all 3 of them ranked in group 5 in the age-and preva-
lence-adjusted rates. Most of the counties that ranked 
the worst for the age-adjusted rates remained ranked in 
group 4 or group 5 in the combined age- and prevalence-
adjusted rates. Stanislaus County and Los Angeles SPA 
1-Antelope Valley were the exceptions; they ranked in 
group 5 in the age-adjusted rate and rose to group 3 in 
the combined rate.
Discussion
This study examined the effect of incorporating disease 
prevalence into the denominator when calculating hospi-
talization rates for hypertension and CHF. CHF has a low 
prevalence in the overall population and a high hospital-
ization rate, and hypertension has a high prevalence in 
the overall population and a low hospitalization rate. After 
incorporating disease prevalence into the rate calculation 
beyond age adjusting, 31 counties were shifted to a new 
CHF group ranking, compared with only 14 counties that 
were shifted to a new hypertension group ranking. 
Higher ACSC hospitalization rates indicate poor quality, 
uncoordinated care, or insufficient access to health care 
(7). Yet, the choice of rate calculation for ACSC hospital-
izations can lead to different conclusions about the effec-
tiveness of primary care services. Crude rates measure 
the overall burden of hospitalizations in a population; 
age-adjusted rates serve as a relative index of risk that 
roughly adjusts for age differentials in disease risk of the 
population (12). These standard rate calculations capture 
the whole population rather than a population that is 
truly at risk for hospitalizations and may underestimate 
the overall burden of preventable hospitalizations. With 
appropriate disease management and lifestyle modifica-
tions, hypertension and congestive heart failure (CHF) 
are chronic conditions that are largely controllable in out-
patient settings. Yet, the complications of CHF are more 
common and evident than those for hypertension; CHF 
is the leading cause of hospitalization in California, espe-
cially among older adults (8,13). 
Little change occurred when accounting for hypertension 
prevalence in the population at risk for a hospitalization. 
Counties with high hospitalization rates, regardless of 
accounting for disease prevalence, continue to be criti-
cal areas for improving outpatient care for hypertension. 
These findings on hypertension refute our hypothesis that 
adjusting for disease prevalence would highlight areas 
of higher disease burden. Although overall hospitaliza-
tion rates are low for hypertension, a 2010 California 
report showed a dramatic increase in hypertension 
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hospitalization rates from 1999 through 2008; the largest 
increase occurred from 2006 through 2008 (outside this 
study period) (8). Future studies should still consider dis-
ease prevalence in calculating hypertension hospitaliza-
tion rates.
Hospitalizations for CHF may be more preventable. 
After adjusting for disease prevalence, more than half of 
California counties changed group rankings. Furthermore, 
counties that reported lower group rankings by standard 
calculations switched to higher group rankings when 
adjusting for CHF prevalence. Areas such as SPA 5-West 
Area in Los Angeles County, Santa Barbara County, and 
Santa Clara County all shifted from low to high hospital-
ization rates. Although these are more affluent areas with 
high incomes and low poverty levels, the low rate of hos-
pitalizations and high rate when adjusted for CHF preva-
lence may point to a higher tendency to hospitalize people 
with CHF. Factors such as low disease prevalence and 
large number of hospital beds may also fuel these hospi-
talization rates and thus create a hospital supply-induced 
care rather than a need-induced care. Although we cannot 
differentiate between supply-induced and need-induced 
care, these rate calculations are based on a patient’s zip 
code of residence and not on referrals into an area with 
better hospitals. Further research is needed to explain the 
higher prevalence-adjusted hospitalization rates in these 
areas to help reduce preventable CHF hospitalizations.
This study has several limitations. First, disease preva-
lence is measured from a population-based survey, where-
as hospitalizations are based on an administrative census 
count. The underdiagnosis of chronic conditions is well 
established from population-based surveys (14,15), and so 
CHIS’s self-reported awareness of diagnosed hypertension 
and CHF may underestimate the true prevalence. The 
rates we calculate will therefore be somewhat inflated, but 
we do not expect any significant bias by county. Previous 
literature has indicated data limitations for hospitalization 
data, including poor quality control and overestimation of 
disease trends (16-18). California’s OSHPD regularly 
conducts a series of audits to ensure validity of hospital-
ization data. If data reports do not meet error tolerance 
levels of less than 0.1%, OSHPD sends the data back to 
the hospital to be corrected (19). To address the potential 
overestimation by OSHPD, we limited hospital records to 
principal diagnosis of hypertension and CHF. Although we 
weighted the population-based CHIS data and examine 
variance of the hospitalization rates,  sampling biases may 
limit the accuracy of the findings.
Second, hospitalization rates have been shown to vary 
widely by sex and race/ethnicity (20-25). Because of low 
ACSC prevalence in some counties, it was difficult to 
obtain stable estimates if we stratified by more than 1 
demographic characteristic. We chose to adjust by age 
because hospitalizations vary most widely between age 
groups, as evident from the age-specific rates. Third, cat-
egories for CHF generated small sample sizes that may 
lead to high variance when incorporating CHF disease 
prevalence into the denominator. This issue affects rate 
calculations most when we stratify by age groups at the 
county level. We attempted to reduce the variation by 
using pooled CHIS data across 3 years and imputing age-
specific disease prevalence where sample sizes are too 
small to report.
The results from this study show that disease prevalence 
should be incorporated into ACSC research. Previous stud-
ies have included disease prevalence as a control variable 
in statistical analysis rather than incorporating disease 
prevalence into the hospitalization rate (23,26-28). By 
incorporating prevalence into hospitalization rate calcula-
tions, we can assess the true population at risk who have 
the disease instead of just the population at large who 
reside in the area. Taking into account disease preva-
lence can highlight areas with higher burden of chronic 
conditions on the health care system (both inpatient and 
outpatient). Because of rising health care costs and the 
anticipated health care reform changes to the health care 
system, our current tools for evaluating health services 
should be assessed. Our proposed method of calculation 
builds on existing methods and offers a relatively simple 
alternative by accounting for people who are truly at risk 
for ACSC hospitalization. By using more accurate mea-
sures, public health officials and health care providers can 
develop more effective community health interventions 
and improve outpatient care for ACSC.
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Tables
Table 1. ACSC Prevalence and Hospitalizations, California Adults Aged 18 Years or Oldera
Characteristic Congestive Heart Failure, N (95% CI) Hypertension, N (95% CI)
Total prevalence 389,839 (35,00-0,28) ,52,53 (,,510-,590,3)
Percentage of population 1.% 2.8%
Prevalence by age, y
18-
19,000 (18,9-215,50)b
1,511,000 (1,5,35-1,55,)
5- 2,30,000 (2,,325-2,83,5)
5- 10,000 (9,18-11,582) 1,123,000 (1,089,103-1,15,89)
≥75 151,000 (10,09-11,90) 1,1,000 (1,130,-1,19,223)
Average hospitalization per year 5,389 ,355
Hospitalizations by age, y
18-
18,39b
90
5- 2,80
5- 13,25 1,138
≥75 33,55 1,9
 Rate (95% CI) Rate (95% CI)
Crude hospitalization ratec 28.8 (28.5-28.) 2.1 (2.1-2.18)
Prevalence-adjusted hospitalization rated 1,3.3 (1,1.33-1,5.3) 9. (9.35-9.3)
Age-adjusted hospitalization ratec 20.2 (2.0-2.) 25.1 (2.-25.8)
Age- and prevalence-adjusted hospitalization rated 10,33.0 (9,85.-11,390.) 81.5 (8.-8.3)
 
Abbreviations: ACSC, ambulatory care–sensitive conditions; OSHPD, Office of Statewide Health Planning and Development; CI, confidence interval. 
a Data were pooled from the California Health Interview Survey for 2003, 2005, and 200 and averaged from OSHPD discharge files for 200, 2005, and 
200.  
b Age groups 18- y and 5- y are combined for this rate because of the small prevalence of congestive heart failure in the population. 
c Rate per 100,000 people in the population. 
d Rate per 100,000 people reporting ACSC in the population.
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Table 2. Age-Adjusted and Age- and Prevalence-Adjusted Hospitalization Rates for Hypertension, California Adults 18 Years or 
Oldera,b
County Cluster/County/Subcounty
Hypertension
Age-Adjusted Rate Age- and Prevalence–Adjusted Rate
Rate (95% CI) Group Rate (95% CI) Group
California 25.1 (2.-25.8) NA 81.5 (8.-8.3) NA
Alameda 21.2 (18.3-2.2)  3.2 (59.2-8.2) 
Butte 25.0 (1.-32.5)  .0 (5.5-10.) 
Contra Costa 15.3 (12.3-18.2) 2 5.1 (3.2-5.1) 2
Del Norte, Siskiyou, Lassen, Trinity, Modoc, Plumas, Sierra 10.0 (.9-15.2) 1 3.5c (12.3-5.) 1
El Dorado 19.9 (12.1-2.) 3 82.c (3.-130.8) 
Fresno 1.9 (1.1-21.) 3 58.0 (3.1-2.8) 3
Humboldt 8.c (2.-1.5) 1 39.3c (3.-.9) 1
Imperial 28.1 (1.-38.)  8.0 (.-125.) 
Kern 25.0 (20.1-30.0)  0.8 (53.-8.9) 
Kings 33.0 (19.0-.0) 5 90.8 (.0-13.) 
Lake 10. (3.-18.0) 1 35.0c (.2-5.8) 1
Los Angeles SPA 1 – Antelope Valley 3.0 (33.1-52.9) 5 139.8 (100.3-19.3) 5
Los Angeles SPA 2 – San Fernando 32. (29.1-35.) 5 100. (8.1-11.1) 5
Los Angeles SPA 3 – San Gabriel Valley 29.9 (2.-33.2)  9.3 (9.5-109.0) 5
Los Angeles SPA  – Metro 1.8 (.1-9.) 5 219.9 (189.3-250.) 5
Los Angeles SPA 5 – West Area 13.5 (10.-1.) 2 5. (30.5-0.9) 2
Los Angeles SPA  – South 5.8 (.0-85.) 5 201. (19.0-23.1) 5
Los Angeles SPA  – East Area 35.3 (30.-39.9) 5 111.9c (93.1-130.) 5
Los Angeles SPA 8 – South Bay 30.9 (2.3-3.5) 5 98.5c (83.5-113.5) 5
Madera 15.3 (.-23.2) 2 2.3c (15.1-9.) 1
Marin 11.1 (.5-15.) 1 8.5 (13.-83.) 2
Mendocino .c (0.5-12.) 1 18. (0.0-2.) 1
Merced 18.5 (11.2-25.8) 3 58.0c (29.-8.3) 3
Monterey 20.5 (15.1-2.0)  .c (8.2-10.0) 
Napa 13.1c (.1-20.2) 2 3.5 (10.2-.8) 2
Nevada 1.c (9.1-25.) 3 8.2c (.0-19.) 
Orange 25.2 (22.-2.)  85. (3.3-9.8) 
 
Abbreviations: CHIS, California Health Interview Survey; OSHPD, Office of Statewide Health Planning and Development; CI, confidence interval; NA, not appli-
cable. 
a Rates are per 100,000 people; Group 1 = lowest rate, Group 5 = highest rate. 
b Data were pooled from the California Health Interview Survey for 2003, 2005, and 200 and averaged from OSHPD discharge files for 200, 2005, and 
200.  
c Rates are unstable estimates with a coefficient of variance of more than 30%.
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County Cluster/County/Subcounty
Hypertension
Age-Adjusted Rate Age- and Prevalence–Adjusted Rate
Rate (95% CI) Group Rate (95% CI) Group
Placer 10.9 (.-15.1) 1 3.8 (1.-58.1) 1
Riverside 2.3 (2.3-30.3)  88.2c (5.0-101.) 
Sacramento 1. (1.0-19.) 3 2. (.1-8.3) 3
San Benito 35.c (1.-5.3) 5 95. (2.-13.) 5
San Bernardino 0.1 (35.8-.3) 5 11. (102.3-132.5) 5
San Diego Region 1--North Coastal 13. (9.5-1.3) 2 0.2 (25.-5.) 1
San Diego Region 2--North Central 1. (10.9-18.) 2 9.2 (32.8-5.) 2
San Diego Region 3--Central 3.0 (2.1-1.9) 5 98.2 (0.2-12.3) 5
San Diego Region --South 20.0 (1.2-25.)  5.0 (1.0-89.1) 3
San Diego Region 5--East 1.8 (10.-19.0) 2 50.5c (31.1-9.9) 2
San Diego Region --North Inland 8.3 (5.2-11.) 1 28. (15.5-1.3) 1
San Francisco 1.9 (13.-20.2) 3 3.8 (.-81.0) 3
San Joaquin 3. (28.5-1.0) 5 93. (3.9-112.9) 5
San Luis Obispo 5. (2.5-8.9) 1 28.2 (3.0-53.3) 1
San Mateo 15.5 (11.9-19.1) 2 3.2 (29.9-5.5) 2
Santa Barbara 11. (.8-15.) 1 3.3 (23.2-3.5) 2
Santa Clara 1.2 (12.0-1.5) 2 9.9 (39.5-0.2) 2
Santa Cruz 1.0 (9.8-22.2) 2 5.5 (2.5-85.5) 3
Shasta 1. (10.8-2.3) 3 5. (28.5-8.) 3
Solano 1.3 (12.2-22.3) 3 51.5c (33.2-9.8) 2
Sonoma .8 (.9-10.) 1 30.1 (13.-.) 1
Stanislaus 19. (1.5-2.) 3 5.c (39.8-3.1) 3
Sutter, Yuba 2. (1.9-33.9)  8.9 (3.-101.5) 
Tehama, Glenn, Colusa 1.1 (8.2-2.0) 3 5.9c (20.2-95.) 3
Tulare 1.5 (12.1-22.9) 3 51.5 (33.1-0.0) 2
Tuolumne, Calaveras, Amador, Inyo, Mariposa, Mono, Alpine 1.3 (8.3-20.3) 2 55. (20.8-90.) 3
Ventura 20. (1.-2.)  5.9 (9.0-82.8) 3
Yolo 9.5 (3.9-15.1) 1 38.5 (12.9-.2) 1
 
Abbreviations: CHIS, California Health Interview Survey; OSHPD, Office of Statewide Health Planning and Development; CI, confidence interval; NA, not appli-
cable. 
a Rates are per 100,000 people; Group 1 = lowest rate, Group 5 = highest rate. 
b Data were pooled from the California Health Interview Survey for 2003, 2005, and 200 and averaged from OSHPD discharge files for 200, 2005, and 
200.  
c Rates are unstable estimates with a coefficient of variance of more than 30%.
Table 2. (continued) Age-Adjusted and Age- and Prevalence-Adjusted Hospitalization Rates for Hypertension, California Adults 18 
Years or Oldera,b
VOLUME 8: NO. 5
SEPTEMBER 2011
 www.cdc.gov/pcd/issues/2011/sep/11_0013.htm • Centers for Disease Control and Prevention 11
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position 
of the Centers for Disease Control and Prevention.
Table 3. Age-Adjusted and Age- and Prevalence-Adjusted Hospitalization Rates for Congestive Heart Failure, California Adults Aged 
18 Years or Oldera,b
County Cluster/County/Subcounty
Congestive Heart Failure
Age-Adjusted Rate Age- and Disease Prevalence-Adjusted Rate
Rate (95% CI) Group Rate (95% CI) Group
CALIFORNIA 20.2 (2.0-2.) NA 10,33.0 (9,85.-11,390.) NA
Alameda 302.2 (29.5-32.9)  11,322.5 (,90.-1,95.) 
Butte 21. (238.9-30.2)  9,9.9 (,102.5-1,893.3) 3
Contra Costa 23. (215.-25.) 3 11,103.2 (,35.9-15,830.5) 3
Del Norte, Siskiyou, Lassen, Trinity, Modoc, Plumas, 
Sierra
1. (19.-199.5) 1 ,52.5c (1,.5-11,22.) 1
El Dorado 203.5 (18.-238.3) 2 8,12.1 (,5.2-11,802.9) 2
Fresno 325. (28.3-3.5) 5 2,.1c (,5.9-1,30.2) 5
Humboldt 22. (18.8-2.) 2 8,3.9 (,0.3-12,028.) 2
Imperial 315. (2.-3.5)  11,15. (5,13.9-1,1.0) 
Kern 31.0 (2.-35.)  8,233.9c (2,509.-13,958.2) 2
Kings 305.1 (2.-32.9)  13,01.2 (,29.9-18,30.5) 
Lake 188.9 (153.9-223.9) 1 ,83.9 (3,30.8-12,333.0) 1
Los Angeles SPA 1 – Antelope Valley 399.8 (3.-53.1) 5 11,29.3 (5,223.8-1,3.8) 3
Los Angeles SPA 2 – San Fernando 280.1 (259.0-301.3)  11,58. (,9.-15,19.8) 
Los Angeles SPA 3 – San Gabriel Valley 285.9 (2.3-305.5)  12,520.9 (8,80.9-1,20.8) 
Los Angeles SPA  – Metro 392.5 (35.9-28.1) 5 15,3.3 (10,30.2-20,9.) 5
Los Angeles SPA 5 – West Area 159.3 (11.8-1.) 1 1,293.c (2,20.-32,31.5) 5
Los Angeles SPA  – South 539.1 (83.-59.5) 5 1,5. (8,23.5-2,889.3) 5
Los Angeles SPA  – East Area 290.8 (25.0-31.)  13,95.8 (,2.-20,39.0) 
Los Angeles SPA 8 – South Bay 259.0 (20.3-2.8) 3 10,1.9 (,133.3-15,390.5) 3
Madera 20. (219.0-302.5) 3 ,813.2 (,93.9-10,932.5) 1
Marin 181. (15.2-20.1) 1 ,82.5 (,3.2-10,91.8) 1
Mendocino 221.2 (1.1-25.3) 2 9,182.2 (,08.-1,285.) 2
Merced 32.9 (29.2-3.) 5 12,081. (,22.1-1,93.1) 
Monterey 229. (198.3-20.9) 3 ,198.8 (,213.8-8,183.8) 1
Napa 21. (181.5-252.0) 2 ,25.5 (3,891.1-10,599.9) 1
Nevada 159.2 (130.1-188.3) 1 ,15.c (1,98.3-11,22.) 1
Orange 29.2 (232.-25.9) 3 10,29.1 (,88.3-13,009.9) 3
 
Abbreviations: CHIS; California Health Interview Survey; OSHPD, Office of Statewide Health Planning and Development; CI, confidence interval. 
a Rates are per 100,000 individuals; Group 1 = lowest rate, Group 5 = highest rate. 
b Data were pooled from the California Health Interview Survey for 2003, 2005, and 200 and averaged from OSHPD discharge files for 200, 2005, and 
200. 
c Rates are unstable estimates with a coefficient of variance of more than 30%.
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County Cluster/County/Subcounty
Congestive Heart Failure
Age-Adjusted Rate Age- and Disease Prevalence-Adjusted Rate
Rate (95% CI) Group Rate (95% CI) Group
Placer 19.3 (19.9-222.) 1 10,19.c (553.0-19,805.) 3
Riverside 258.3 (22.-2.3) 3 ,88. (5,2.3-9,995.2) 2
Sacramento 2. (25.3-29.9)  9,0.0 (,2.-12,085.) 3
San Benito 252.3 (15.2-329.3) 3 1,30.9c (0.0-3,9.1) 5
San Bernardino 3. (318.2-30.5) 5 12,5.2 (9,302.0-1,28.3) 
San Diego Region 1 – North Coastal 191.8 (1.8-21.) 1 9,031. (3,10.-1,95.5) 2
San Diego Region 2 — North Central 189.2 (11.1-21.3) 1 10,82.0 (,899.0-1,5.9) 3
San Diego Region 3 — Central 19.9 (3.5-92.3) 5 1,329. (8,129.2-20,530.1) 
San Diego Region  — South 35.0 (295.-18.5) 5 12,83.5 (,21.3-19,0.) 
San Diego Region 5 — East 198. (11.3-22.1) 2 3,2. (2,23.8-,81.) 1
San Diego Region  — North Inland 18.5 (159.-213.2) 1 ,352.9c (2,52.-12,181.1) 1
San Francisco 233.1 (20.2-258.9) 3 21,102.1c (1,39.-0,.) 5
San Joaquin 3.2 (323.2-09.2) 5 25,31.9 (1,59.8-3,080.1) 5
San Luis Obispo 1.2 (12.5-191.9) 1 8,05.2 (3,3.-12,3.) 2
San Mateo 203.9 (18.-229.1) 2 12,55.0c (,385.9-20,2.0) 
Santa Barbara 200.3 (12.8-22.8) 2 1,21.1c (0.0-33,121.) 5
Santa Clara 208.3 (190.1-22.5) 2 1,988.8 (10,321.0-23,5.) 5
Santa Cruz 20.5 (22.-31.) 3 30,.c (0.0-3,032.0) 5
Shasta 20. (210.3-21.1) 3 11,0.1 (5,02.-1,01.5) 3
Solano 298.0 (25.8-338.3)  8,132.8 (,09.5-10,19.0) 2
Sonoma 19.3 (11.8-222.9) 1 8,153. (,3.3-11,0.8) 2
Stanislaus 33.0 (295.-38.3) 5 9,800.9 (5,8.-13,923.) 3
Sutter, Yuba 318.9 (2.-33.2) 5 1,9.0 (9,25.1-2,3.0) 5
Tehama, Glenn, Colusa 258. (215.3-301.5) 3 8,12.2 (3,82.2-12,2.2) 2
Tulare 313.9 (23.-35.2)  10,150.5 (5,832.-1,8.) 3
Tuolumne, Calaveras, Amador, Inyo, Mariposa, Mono, 
Alpine
209.2 (180.-23.9) 2 5,99. (2,82.0-9,01.) 1
Ventura 222.9 (19.3-251.) 2 ,90.9c (2,9.9-13,318.8) 2
Yolo 221. (182.5-20.9) 2 ,35. (3,290.-9,22.) 1
 
Abbreviations: CHIS; California Health Interview Survey; OSHPD, Office of Statewide Health Planning and Development; CI, confidence interval. 
a Rates are per 100,000 individuals; Group 1 = lowest rate, Group 5 = highest rate. 
b Data were pooled from the California Health Interview Survey for 2003, 2005, and 200 and averaged from OSHPD discharge files for 200, 2005, and 
200. 
c Rates are unstable estimates with a coefficient of variance of more than 30%.
Table 3. (continued) Age-Adjusted and Age- and Prevalence-Adjusted Hospitalization Rates for Congestive Heart Failure, California 
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Appendices
Appendix A. Measures for Ambulatory Care–Sensitive Conditions from OSHPD and CHIS Data
ACS Condition
Hospitalizationsa by ICD-9-CM Codes (OSHPD 
Principal Diagnosis) Disease Prevalence (CHIS Self-Report)
Congestive heart failure (PQI #8) 28, 02.01, 02.11, 02.91, 518. 
Age groups: 18-64, 65-74, and ≥75 y
Adults who reported ever having been diagnosed with 
congestive heart failure by a doctor.
Hypertension (PQI #7) 01.0, 01.9, 02.00, 02.1, 02.9 
Age groups: 18-44, 45-64, 65-74, and ≥75 y
Adults who reported ever having been diagnosed with 
high blood pressure or hypertension by a doctor.
 
Abbreviations: OSHPD, Office of Statewide Health Planning and Development; CHIS, California Health Interview Survey; ICD-9-CM, International Classification of 
Diseases, Ninth Revision, Clinical Modification. 
a California hospitals include general acute care hospitals, acute psychiatric hospitals, chemical dependency recovery hospitals, and psychiatric health facili-
ties. Excludes transfer from a hospital (different facility), a skilled nursing facility or intermediate care facility, or another health care facility; and MDC 1 (preg-
nancy). Only 1 hospital record was used for patients who had multiple hospital admissions for the same principle diagnosis per year.
Appendix B. Methods for Calculating Hospitalization Rates and Data Sources
Standard Methods
1. Crude Hospitalization Rate
Total # Hospitalizations in County
Total # People in County
Numerator: OSHPD data 200-200
Denominator: CHIS data, 2005 population estimates
Variance =  
2. Age-Adjusted Hospitalization Rate
∑[Age–Specific Rates (Age Group 1) X (Standard Population (Age Group 1)]
Total # People in Standard Population
Age-Specific Rates =
[Total # Hospitalizations in County (Age Group 1)]
[Total # People in County (Age Group 1)]
 
Age- and Prevalence-Specific Rate Numerator: OSHPD data 200-200 
Age- and Prevalence-Specific Rate Denominator: CHIS data (2003, 2005, 200) disease prevalence estimates
Variance = Sum of the age-specific rate variances    
(Continued on next page)
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Methods That Incorporate Disease Prevalence
3. Prevalence-Adjusted Hospitalization Rate
Total # Hospitalizations in County
Total # People Reporting ACS Condition in County
Numerator: OSHPD data, 200-200
Denominator: CHIS pooled data (2003, 2005, 200) disease prevalence estimates
Variance =
4. Age- and Prevalence-Adjusted Hospitalization Rate
∑[Age- and Prevalence–Specific Rates (Age Group 1) X (Standard Population (Age Group 1)]
Total # People in Standard Population
Age- and Prevalence-Specific Rates =
Total # Hospitalizations in County (Age Group 1)
[Total # People Reporting ACS Condition in County (Age Group 1)]
Standard Population: US Census 2000 population
Age- and Prevalence-Specific Rate Numerator: OSHPD Data 200-200 
Age- and Prevalence-Specific Rate Denominator: CHIS Data (2003, 2005, 200) Disease Prevalence Estimates
Variance = Sum of the age-specific rate variances  
 
Abbreviations: OSHPD, Office of Statewide Health Planning and Development; CHIS, California Health Interview Survey; ACS, ambulatory care sensitive.
Appendix B. (continued) Methods for Calculating Hospitalization Rates and Data Sources
